CARDLYTICS INC - NOTE 1.000% 9/1

Q1 2022 13F Holders as of 3/31/2022

Type / Class
Debt / NOTE 1.000% 9/1
Number of holders
13
Total 13F principal, excl. options
232M
Principal change
+2.76M
Total reported value, excl. options
$236M
Value change
+$2.13M
Number of buys
5
Number of sells
-7
Price
$1.02

Significant Holders of CARDLYTICS INC - NOTE 1.000% 9/1 as of Q1 2022

18 filings reported holding 14161WAB1 - CARDLYTICS INC - NOTE 1.000% 9/1 as of Q1 2022.
CARDLYTICS INC - NOTE 1.000% 9/1 has 13 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $232M of principal .
Largest 10 bondholders include CITADEL ADVISORS LLC ($98.5M of principal), Linden Advisors LP ($65.6M of principal), WOLVERINE ASSET MANAGEMENT LLC ($38.5M of principal), CAPSTONE INVESTMENT ADVISORS, LLC ($10M of principal), GABELLI FUNDS LLC ($6.92M of principal), GUARDIAN POINT CAPITAL, LP ($5M of principal), 683 Capital Management, LLC ($2M of principal), BARCLAYS PLC ($1.76M of principal), Nicholas Investment Partners, LP ($1.39M of principal), and Teton Advisors, Inc. ($1.03M of principal).
This table shows the top 13 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.